GIMBHI: Talkspace (TALK) Q3 2025 Earnings
Sources: Talkspace, Claude
Additional Information: Talkspace (TALK) Q3 FY2025 Earnings Call Transcript
Financial Performance
Revenue $59.4M (25% YoY, 9% sequential)
Payer revenue $45.5M (42% YoY, 12% sequential)
Adjusted EBITDA $5M (111% YoY, 8.4% margin)
OpEx as % revenue: 34% (down from 41% YoY)
Gross margin 41.5% (down from 43.1% due to pre-hiring)
LTM Adjusted EBITDA ~$11.9M vs ~$4M YoY
$96M cash, $0 debt, $17M buybacks YTD
2025 guidance: $226–230M revenue (20–23% growth), $14–16M EBITDA
Unit Economics & Engagement
120K active payer members (29% YoY, highest since inception)
432K payer sessions (37% YoY)
~3.6 sessions/member/quarter
Third session completion in 30 days up 50%
Payer members show longer retention than out-of-pocket
Consumer revenue deliberately declining ($6M→$4.6M YoY) as pushing to insurance
AI/LLM Differentiation
Trained on “hundreds of millions” anonymized therapy transcripts
50% better identifying high-risk behaviors vs general LLMs
47% higher therapeutic quality score
3x higher user satisfaction
30% higher third session booking with AI insights
21% more likely to book third session after AI podcast
Launching behavioral health LLM H1 2026
Built-in HIPAA compliance + human therapist handoff
Network & Operations
6,000 clinicians network
Psychiatry providers grew 50% in Q2
Psychiatry initial sessions up 46% quarterly
Cross-referral therapy↔psychiatry driving sessions/member increase
93% of NYC teen program users prefer messaging over video
500+ suicide risk incidents identified in teen program
Market Position & Strategy
35% brand recognition as insurance-focused mental health brand
In-network with new BCBS Illinois and Massachusetts
Won competitive takeaway of major national EAP
Military/dependents emerging as key growth segment
Medicare still “work in progress” — different engagement by age cohorts
DTE launches delayed Q3→Q4 but visibility strong
Strategic Acquisitions & Partnerships
Acquired WISDO Health (AI peer support, 500K users, 21% loneliness reduction, 10% reduction ER/urgent care visits)
Novo Nordisk/Wegovy partnership for GLP-1 group coaching
Fee-for-service model with past cohorts compounding
Pharma channel entry opportunity
Subscribe to news and reports about mental health startups & mental health investors at gimbhi.substack.com